Hepatitis: CXCL10 antagonism may contribute to the inability of patients to clear HCV

被引：0
|
作者：
Greenhill C.
机构：
来源：
Nature Reviews Gastroenterology & Hepatology | 2011年 / 8卷 / 3期
关键词：
D O I：
10.1038/nrgastro.2011.8
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：121 / 121
相关论文
共 50 条
  • [1] EVIDENCE FOR CXCL10 (IP-10) ANTAGONISM IN CHRONIC HCV INFECTION
    Mallet, V.
    Casrouge, A.
    Vallet-Pichard, A.
    Ahloulay, M.
    Pol, S.
    Albert, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S122 - S122
  • [2] CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients
    Ragab, Dina
    Laird, Melissa
    Duffy, Darragh
    Casrouge, Armanda
    Mamdouh, Rasha
    Abass, Amal
    El Shenawy, Dina
    Shebl, Abdelhadi M.
    Elkashef, Wagdi F.
    Zalata, Khaled R.
    Kamal, Mostafa
    Esmat, Gamal
    Bonnard, Philippe
    Fontanet, Arnaud
    Rafik, Mona
    Albert, Matthew L.
    CYTOKINE, 2013, 63 (02) : 105 - 112
  • [3] Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
    Ferrari, Silvia Martina
    Fallahi, Poupak
    Ruffilli, Ilaria
    Elia, Giusy
    Ragusa, Francesca
    Paparo, Sabrina Rosaria
    Patrizio, Armando
    Mazzi, Valeria
    Colaci, Michele
    Giuggioli, Dilia
    Ferri, Clodoveo
    Antonelli, Alessandro
    JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
  • [4] Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
    Casrouge, Armanda
    Decalf, Jeremie
    Ahloulay, Mina
    Lababidi, Cyril
    Mansour, Hala
    Vallet-Pichard, Anais
    Mallet, Vincent
    Mottez, Estelle
    Mapes, James
    Fontanet, Arnaud
    Pol, Stanislas
    Albert, Matthew L.
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (01): : 308 - 317
  • [5] CXCL10: An important determinant of inflammation in chronic HCV infection?
    Petrovic, LM
    Zeremski, M
    Brown, Q
    Chiriboga, L
    Yee, H
    Talal, AH
    MODERN PATHOLOGY, 2006, 19 : 279A - 279A
  • [6] CXCL10: An important determinant of inflammation in chronic HCV infection?
    Petrovic, LM
    Zeremski, M
    Brown, Q
    Chiriboga, L
    Yee, H
    Talal, AH
    LABORATORY INVESTIGATION, 2006, 86 : 279A - 279A
  • [7] Preoperative serum CXCL10 is an independent prognostic factor for patients with clear cell ovarian carcinoma
    Yabuno, A.
    Hasegawa, K.
    Matsushita, H.
    Sato, S.
    Kurosaki, A.
    Yoshida, H.
    Kakimi, K.
    Fujiwara, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 859 - 859
  • [8] CXCL10 May Be Responsible for Susceptibility to Pulmonary Embolism in COVID-19 Patients
    Liu, Yingli
    Si, Dan
    Bai, Pingping
    Zhu, Li
    Zhang, Lili
    Chen, Qi
    Qi, Yong
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 4913 - 4924
  • [9] Elevated serum concentrations of IP-10/CXCL10 in HIV/HCV co-infected patients
    Roe, B.
    Coughlan, S.
    Hassan, J.
    Grogan, A.
    Farrell, G.
    Norris, S.
    Bergin, C.
    Hall, W. W.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S174 - S175
  • [10] Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10
    Zhang, Ren-Wen
    Shao, Cui-Ping
    Huo, Na
    Li, Min-Ran
    Xi, Hong-Li
    Yu, Min
    Xu, Xiao-Yuan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (33) : 9765 - 9773
12345